NYSE:CVS - CVS Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CVS Health Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $75.36 +0.88 (+1.18 %) (As of 12/8/2019 02:39 PM ET) Add Compare Today's Range$75.00Now: $75.36▼$75.7550-Day Range$64.94MA: $71.11▼$76.3952-Week Range$51.72Now: $75.36▼$77.03Volume5.06 million shsAverage Volume6.11 million shsMarket Capitalization$98.04 billionP/E Ratio10.64Dividend Yield2.69%Beta0.89 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Drug stores & proprietary stores Sub-IndustryDrug Retail SectorRetail/Wholesale Current SymbolNYSE:CVS Previous Symbol CUSIP12665010 CIK64803 Webhttp://www.cvshealth.com/ Phone401-765-1500Debt Debt-to-Equity Ratio1.32 Current Ratio0.92 Quick Ratio0.61Price-To-Earnings Trailing P/E Ratio10.64 Forward P/E Ratio10.72 P/E Growth1.61 Sales & Book Value Annual Sales$194.58 billion Price / Sales0.50 Cash Flow$16.17 per share Price / Cash Flow4.66 Book Value$57.46 per share Price / Book1.31Profitability EPS (Most Recent Fiscal Year)$7.08 Net Income$-594,000,000.00 Net Margins1.83% Return on Equity15.45% Return on Assets4.39%Miscellaneous Employees295,000 Outstanding Shares1,300,960,000Market Cap$98.04 billion Next Earnings Date2/19/2020 (Estimated) OptionableOptionable Receive CVS News and Ratings via Email Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter. CVS Rates by TradingView CVS Health (NYSE:CVS) Frequently Asked Questions What is CVS Health's stock symbol? CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS." How often does CVS Health pay dividends? What is the dividend yield for CVS Health? CVS Health declared a quarterly dividend on Thursday, October 3rd. Investors of record on Thursday, October 24th will be given a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 annualized dividend and a yield of 2.65%. The ex-dividend date is Wednesday, October 23rd. View CVS Health's Dividend History. How were CVS Health's earnings last quarter? CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.77 by $0.07. The pharmacy operator earned $64.81 billion during the quarter, compared to analyst estimates of $62.99 billion. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The firm's quarterly revenue was up 36.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.73 earnings per share. View CVS Health's Earnings History. When is CVS Health's next earnings date? CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for CVS Health. What guidance has CVS Health issued on next quarter's earnings? CVS Health updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided earnings per share (EPS) guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.98. What price target have analysts set for CVS? 25 analysts have issued 12 month price objectives for CVS Health's shares. Their forecasts range from $61.00 to $91.00. On average, they anticipate CVS Health's share price to reach $77.14 in the next twelve months. This suggests a possible upside of 2.4% from the stock's current price. View Analyst Price Targets for CVS Health. What is the consensus analysts' recommendation for CVS Health? 25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health. Has CVS Health been receiving favorable news coverage? Press coverage about CVS stock has been trending extremely positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a news sentiment score of 5.0 on InfoTrie's scale. They also assigned news headlines about the pharmacy operator a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for CVS Health. Who are some of CVS Health's key competitors? Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Petmed Express (PETS), Rite Aid (RAD), Diplomat Pharmacy (DPLO), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP). What other stocks do shareholders of CVS Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), NVIDIA (NVDA), Alibaba Group (BABA), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Home Depot (HD), Verizon Communications (VZ), Bank of America (BAC) and Intel (INTC). Who are CVS Health's key executives? CVS Health's management team includes the folowing people: Mr. Larry J. Merlo, Pres, CEO & Director (Age 63)Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)Mr. Derica W. Rice, Exec. VP & Pres of CVS Caremark (Age 54) Who are CVS Health's major shareholders? CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (4.66%), Parnassus Investments CA (0.64%), Boston Partners (0.63%), Veritas Asset Management LLP (0.52%), Parametric Portfolio Associates LLC (0.42%) and Sumitomo Mitsui Trust Holdings Inc. (0.38%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health. Which institutional investors are selling CVS Health stock? CVS stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, Focused Investors LLC, Boston Partners, Sumitomo Mitsui Trust Holdings Inc., Diamond Hill Capital Management Inc., Russell Investments Group Ltd., State Street Corp and State of New Jersey Common Pension Fund D. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health. Which institutional investors are buying CVS Health stock? CVS stock was bought by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Artemis Investment Management LLP, Haverford Trust Co., California Public Employees Retirement System, Polaris Greystone Financial Group LLC, Atalanta Sosnoff Capital LLC, Parametric Portfolio Associates LLC and Point72 Asset Management L.P.. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health. How do I buy shares of CVS Health? Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is CVS Health's stock price today? One share of CVS stock can currently be purchased for approximately $75.36. How big of a company is CVS Health? CVS Health has a market capitalization of $98.04 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health. What is CVS Health's official website? The official website for CVS Health is http://www.cvshealth.com/. How can I contact CVS Health? CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected] MarketBeat Community Rating for CVS Health (NYSE CVS)Community Ranking: 3.2 out of 5 ( )Outperform Votes: 1,235 (Vote Outperform)Underperform Votes: 706 (Vote Underperform)Total Votes: 1,941MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/8/2019 by MarketBeat.com StaffFeatured Article: Why does a company issue an IPO?